Skip to main content
BCAX logo

BCAX · Bicara Therapeutics Inc. · Short Interest

Track BCAX — free
$18.37 +0.90 (+5.13%)
Market Cap
$1.13B
Shares
66.17M
Volume · Oct 20 212.16K Avg daily vol (3M) 668.21K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

BCAX Latest Reported Short Interest

FINRA reported 10,693,490 BCAX shares sold short as of the September 30, 2026 settlement date, a decrease of 498,234 shares. Days to cover was 14.20 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

BCAX Short Interest Forecast

Equibles' model estimates 10,729,276 shares sold short for the October 15, 2026 settlement, +0.3% versus the latest reported position, with a likely range of 9,819,859 to 11,664,574 shares. This model prediction uses FINRA data through October 15, 2026; FINRA's official release is expected October 26, 2026.

Model estimate

Expected Oct 15 short interest

as of Oct 15 Low confidence 49% chance it rises
10,729,276 +0.3% vs reported
Likely range 9,819,859 to 11,664,574 The latest estimate appears in the chart below. Official release expected Oct 26. Methodology
Short Squeeze Score
60/100
Short interest 16.2% of shares — P96 Days to cover 14.2 — P95 Price vs VWAP -20.9% — P21 Short-volume trend -16.1% — P10 Short interest change -4.5% — P35 Worst FTD 0.00% of shares — P40

Positioning score 59.9 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-30). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

No listed expiration after today falls within the next 30 calendar days.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-20 17:30 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-10-30 Scheduled
FINRA publishes Nov 10
— — — —
2026-10-15 Scheduled
FINRA publishes Oct 26
— — — —
2026-09-30 10,693,490 11,191,724 -498,234 14.20
2026-09-15 11,191,724 10,845,514 +346,210 22.56
2026-08-31 10,845,514 10,463,188 +382,326 22.08
2026-08-14 10,463,188 9,597,404 +865,784 13.28
2026-07-31 9,597,404 9,315,906 +281,498 20.42
2026-07-15 9,315,906 10,121,649 -805,743 12.69
2026-06-30 10,121,649 10,160,393 -38,744 7.33
2026-06-15 10,160,393 10,083,302 +77,091 19.76
2026-05-29 10,083,302 9,849,290 +234,012 22.49
2026-05-15 9,849,290 8,896,472 +952,818 17.31
2026-04-30 8,896,472 9,325,843 -429,371 21.35
2026-04-15 9,325,843 9,639,901 -314,058 14.67
2026-03-31 9,639,901 9,360,506 +279,395 16.49
2026-03-13 9,360,506 9,268,841 +91,665 15.12
2026-02-27 9,268,841 8,813,695 +455,146 14.81
2026-02-13 8,813,695 8,899,892 -86,197 26.85
2026-01-30 8,899,892 8,909,119 -9,227 21.59
2026-01-15 8,909,119 9,148,792 -239,673 18.80
2025-12-31 9,148,792 8,018,780 +1,130,012 15.01
2025-12-15 8,018,780 7,655,080 +363,700 12.25
2025-11-28 7,655,080 7,218,989 +436,091 10.15
2025-11-14 7,218,989 6,457,982 +761,007 10.67
2025-10-31 6,457,982 5,679,088 +778,894 8.03

Full FINRA short interest reporting calendar

Showing 1–23 of 23 settlements
Key facts CIK 2023658 CUSIP 055477103 13F (30d) 9 filings 9 filers Visit website Investor relations